Clearmind Medicine Inc. Common Shares (CMND) Peer Comparison

$1.34

$-0.37 (-21.47%)

As on 04-Sep-2026 13:39EDT

Market cap

$3 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

0.2

Div. Yield

0 %

Edit

	Clearmind Medicine Inc. Common Shares (CMND)	Mesoblast - ADR
Market cap ($ Mln)	3	2,262
Revenue ($ Mln)	--	120
Net Profit ($ Mln)	-7.90	-57.50
Net Margin (%)	--	-144.33
RoE (%)	-120.06	-9.86
Price to Earnings	--	--
Price-To-Book	0.23	4.15

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement ($ Mln)

	Clearmind Medicine Inc. Common Shares (CMND)	Mesoblast - ADR
Operating Revenue	0.00	17.20
Cost of Revenue	0.05	5.13
Gross Profit	-0.05	12.07
Operating Expenses	5.62	74.51
Operating Profit (EBIT)	-5.67	-62.44
Other Income	--	--
Profit before Tax	-3.79	-101.81
Provision for Tax	0.07	0.33
Profit after Tax (Net Income)	-3.86	-102.14
Minority Interest	--	--
Consolidated Profit	--	--

Liabilities ($ Mln)

	Clearmind Medicine Inc. Common Shares (CMND)	Mesoblast - ADR
Shareholder's Funds	1.19	597.44
Minority Interest	--	--
Non-Current Liabilities	0.00	84.62
Current Liabilities	4.89	102.63
Total Liabilities	6.08	784.68

Assets ($ Mln)

	Clearmind Medicine Inc. Common Shares (CMND)	Mesoblast - ADR
Non-Current Assets	0.14	580.33
Current Assets	5.95	204.35
Total Assets	6.08	784.68
Total Debt*	1.78	128.16
Net Current Assets	1.06	101.72

Cashflow ($ Mln)

	Clearmind Medicine Inc. Common Shares (CMND)	Mesoblast - ADR
Cash From Operating Activities	-4.73	-49.95
Cash Flow from Investing Activities	-0.54	0.12
Cash from Financing Activities	2.62	147.34
Net Cash Inflow / Outflow	--	--

Ratios

Profitability Ratios

	Clearmind Medicine Inc. Common Shares (CMND)	Mesoblast - ADR
ROCE (%)	-104.65	-15.42
ROE (%)	-139.78	-18.95
ROA (%)	-47.67	-14.05
EBIT Margin (%)	--	--
Net Margin (%)	--	-593.92
Cash Profit Margin (%)	--	--

Growth Ratios

	Clearmind Medicine Inc. Common Shares (CMND)	Mesoblast - ADR
Revenue Growth (%)	--	1.91
EBIT Growth (%)	--	--
Net Profit Growth (%)	26.61	-16.13
EPS Growth (%)	--	-0.02
Book Value Growth (%)	--	--

Valuation Ratios

	Clearmind Medicine Inc. Common Shares (CMND)	Mesoblast - ADR
Price / Earnings	--	-13.58
Price / Book Value	--	2.32
Dividend Yield (%)	--	--
EV/EBITDA	1.02	-18.38
Market Cap ($ Cr)	--	--

Solvency Ratios

	Clearmind Medicine Inc. Common Shares (CMND)	Mesoblast - ADR
Debt to Equity	1.49	0.21
Short term debt to equity ratio	1.49	0.10
Current Ratio	1.22	1.99
Quick Ratio	--	1.77
Interest Coverage	-192.82	-3.49

Operating Efficiency Ratios

	Clearmind Medicine Inc. Common Shares (CMND)	Mesoblast - ADR
Debtors to sales (%)	--	86.44
Asset Turnover	0.00	0.02
Receivable days	--	380.35
Inventory Days	-112.18	791.94
Payable days	5,232.54	931.00
Cash Conversion Cycle	--	241.30

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly